deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT00459628

Trial of Tomotherapy in Breast Cancer (TomoBreast)

Randomized Trial Comparing Conventional vs Short-course Reduced Volume Conformal Post-surgery Radiation Treatment in Women With Stage I or II Breast Cancer

Sponsor: Vrije Universiteit Brussel

Updated 7 times since 2017 Last updated: May 12, 2017 Started: May 31, 2007 Primary completion: Aug 31, 2011 Completion: Dec 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Neoplasms, this trial is ongoing. The trial is conducted by Vrije Universiteit Brussel and has accumulated 7 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jul 2017 · 6 months · monthly snapshotUnknown Status~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshotActive Not Recruiting~Jun 2019 – ~Jan 2021 · 19 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  4. Jun 2019 — Jan 2021 [monthly]

    Unknown Status NA

    Status: Active Not RecruitingUnknown Status

  5. Jun 2018 — Jun 2019 [monthly]

    Active Not Recruiting NA

Show 2 earlier versions
  1. Jul 2017 — Jun 2018 [monthly]

    Active Not Recruiting NA

    Status: Unknown StatusActive Not Recruiting · Phase: PHASE3NA

  2. Jan 2017 — Jul 2017 [monthly]

    Unknown Status PHASE3

    First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Vrije Universiteit Brussel
Data source: Vrije Universiteit Brussel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations